Search Result
Results for "
scrambled-
" in MedChemExpress (MCE) Product Catalog:
| Cat. No. |
Product Name |
Target |
Research Areas |
Chemical Structure |
- HY-149906D
-
|
|
HIV
|
Infection
|
|
Trecovirsen sodium scrambled negative control is the sequence scrambled negative control of Trecovirsen sodium.
|
-
- HY-177656B
-
|
|
PNPLA3
|
Metabolic Disease
|
|
Pivicasiran sodium scrambled negative control is the sequence scrambled negative control of Pivicasiran sodium.
|
-
- HY-147262A
-
-
- HY-P3392C
-
|
|
FAP
|
Neurological Disease
|
|
Zilganersen sodium scrambled negative control is the sequence scrambled negative control of Zilganersen sodium.
|
-
- HY-177619B
-
|
|
Serpin
|
Others
|
|
Belcesiran sodium scrambled negative control is the sequence scrambled negative control of Belcesiran sodium.
|
-
- HY-153483C
-
-
- HY-132586C
-
-
- HY-132613A
-
-
- HY-177658B
-
|
|
Dystrophin
|
Others
|
|
Renadirsen sodium scrambled negative control is the sequence scrambled negative control of Renadirsen sodium.
|
-
- HY-177622B
-
|
|
IGF-1R
|
Metabolic Disease
|
|
Cibrigirsen sodium scrambled negative control is the sequence scrambled negative control of Cibrigirsen sodium.
|
-
- HY-177973A
-
-
- HY-148130C
-
|
|
E1/E2/E3 Enzyme
|
Others
|
|
Rugonersen sodium scrambled negative control is the sequence scrambled negative control of Rugonersen sodium.
|
-
- HY-145721C
-
-
- HY-132611C
-
-
- HY-177652B
-
-
- HY-142118C
-
|
|
TGF-beta/Smad
|
Cancer
|
|
Trabedersen sodium scrambled negative control is the sequence scrambled negative control of Trabedersen sodium.
|
-
- HY-132591C
-
-
- HY-132608A
-
-
- HY-132610E
-
-
- HY-177671B
-
|
|
ANGPTL
|
Metabolic Disease
|
|
Zodasiran sodium scrambled negative control is the sequence scrambled negative control of Zodasiran sodium.
|
-
- HY-109528A
-
|
|
CMV
|
Infection
|
|
Fomivirsen sodium scrambled negative control is the sequence scrambled negative control of Fomivirsen sodium.
|
-
- HY-177971A
-
-
- HY-148089C
-
-
- HY-177664B
-
-
- HY-148413A
-
|
|
PKC
|
Cancer
|
|
Aprinocarsen sodium scrambled negative control is the sequence scrambled negative control of Aprinocarsen sodium.
|
-
- HY-177643B
-
|
|
COX
|
Cancer
|
|
Lixadesiran sodium scrambled negative control is the sequence scrambled negative control of Lixadesiran sodium.
|
-
- HY-164419B
-
|
|
GHR
|
Others
|
|
Atesidorsen sodium scrambled negative control is the sequence scrambled negative control of Atesidorsen sodium.
|
-
- HY-118874C
-
|
|
Bcl-2 Family
Apoptosis
|
Cancer
|
|
Oblimersen sodium scrambled negative control is the sequence scrambled negative control of Oblimersen sodium.
|
-
- HY-153497C
-
|
|
ANGPTL
|
Metabolic Disease
|
|
Vupanorsen sodium scrambled negative control is the sequence scrambled negative control of Vupanorsen sodium.
|
-
- HY-177669B
-
|
|
Factor XI
|
Metabolic Disease
|
|
Vortosiran sodium scrambled negative control is the sequence scrambled negative control of Vortosiran sodium.
|
-
- HY-177666B
-
|
|
ANGPTL
|
Metabolic Disease
|
|
Solbinsiran sodium scrambled negative control is the sequence scrambled negative control of Solbinsiran sodium.
|
-
- HY-177629B
-
|
|
PNPLA3
|
Neurological Disease
|
|
Elsunersen sodium scrambled negative control is the sequence scrambled negative control of Elsunersen sodium.
|
-
- HY-151123C
-
-
- HY-112980C
-
-
- HY-145722D
-
|
|
HSP
|
Cancer
|
|
Apatorsen sodium scrambled negative control is the sequence scrambled negative control of Apatorsen sodium.
|
-
- HY-147426C
-
-
- HY-177644B
-
|
|
Connexin
|
Others
|
|
Lufepirsen sodium scrambled negative control is the sequence scrambled negative control of Lufepirsen sodium.
|
-
- HY-145728D
-
-
- HY-177611B
-
-
- HY-177653B
-
-
- HY-150212C
-
-
- HY-132580D
-
|
|
SOD
|
Neurological Disease
|
|
Tofersen sodium scrambled negative control is the sequence scrambled negative control of Tofersen sodium.
|
-
- HY-177659B
-
|
|
Dystrophin
|
Others
|
|
Rimigorsen sodium scrambled negative control is the sequence scrambled negative control of Rimigorsen sodium.
|
-
- HY-177616B
-
|
|
Akt
|
Cancer
|
|
Archexin sodium scrambled negative control is the sequence scrambled negative control of Archexin sodium.
|
-
- HY-177615B
-
|
|
E1/E2/E3 Enzyme
|
Others
|
|
Apazunersen sodium scrambled negative control is the sequence scrambled negative control of Apazunersen sodium.
|
-
- HY-158820B
-
-
- HY-147267C
-
-
- HY-153479C
-
-
- HY-164221B
-
|
|
17β-HSD
|
Metabolic Disease
|
|
Rapirosiran sodium scrambled negative control is the sequence scrambled negative control of Rapirosiran sodium.
|
-
- HY-164740B
-
-
- HY-177631B
-
|
|
Prion Protein
|
Cancer
|
|
Etidaligide sodium scrambled negative control is the sequence scrambled negative control of Etidaligide sodium.
|
-
- HY-160040B
-
-
- HY-177634B
-
-
- HY-153484C
-
-
- HY-132589C
-
-
- HY-153492C
-
-
- HY-158825A
-
|
|
PCSK9
|
Metabolic Disease
|
|
Cepadacursen sodium scrambled negative control is the sequence scrambled negative control of Cepadacursen sodium.
|
-
- HY-132604C
-
-
- HY-139786C
-
|
|
Sodium Channel
|
Others
|
|
Cofirasersen sodium scrambled negative control is the sequence scrambled negative control of Cofirasersen sodium.
|
-
- HY-147253C
-
-
- HY-153491B
-
-
- HY-177610B
-
|
|
HPV
|
Infection
|
|
Afovirsen sodium scrambled negative control is the sequence scrambled negative control of Afovirsen sodium.
|
-
- HY-108764B
-
-
- HY-147406C
-
-
- HY-109561A
-
-
- HY-148370C
-
-
- HY-177621B
-
-
- HY-177972A
-
-
- HY-147410C
-
-
- HY-139787C
-
-
- HY-P1513A
-
|
|
Bacterial
|
Infection
|
|
LL-37 scrambled peptide acetate is a scrambled version of cathelicidin anti-microbial peptide LL-37. LL-37 scrambled peptide acetate can be used as a negative control of LL-37 peptide studies.
|
-
- HY-P1513
-
|
|
Bacterial
|
Infection
|
|
LL-37 scrambled peptide is a scrambled version of cathelicidin anti-microbial peptide LL-37. LL-37 scrambled peptide can be used as a negative control of LL-37 peptide studies.
|
-
- HY-139290C
-
|
|
MicroRNA
|
Cancer
|
|
RGLS4326 sodium scrambled negative control is the sequence scrambled negative control of RGLS4326 sodium.
|
-
- HY-148687C
-
-
- HY-153482C
-
-
- HY-148689C
-
|
|
PCSK9
|
Metabolic Disease
|
|
SPC4061 sodium scrambled negative control is the sequence scrambled negative control of SPC4061 sodium.
|
-
- HY-153999C
-
|
|
Integrin
|
Cardiovascular Disease
|
|
Rondaptivon pegol sodium scrambled negative control is the sequence scrambled negative control of Rondaptivon pegol sodium.
|
-
- HY-158829A
-
|
|
EGFR
|
Cancer
|
|
SSOe26 sodium scrambled negative control is the sequence scrambled negative control of SSOe26 sodium.
|
-
- HY-160041B
-
|
|
CXCR
|
Cancer
|
|
Olaptesed pegol sodium scrambled negative control is the sequence scrambled negative control of Olaptesed pegol sodium.
|
-
- HY-177635B
-
|
|
IFNAR
|
Cancer
|
|
GNKG168 sodium scrambled negative control is the sequence scrambled negative control of GNKG168 sodium.
|
-
- HY-159692C
-
-
- HY-158827B
-
|
|
PCSK9
|
Metabolic Disease
|
|
AZD8233 sodium scrambled negative control is the sequence scrambled negative control of AZD8233 sodium.
|
-
- HY-159695B
-
-
- HY-160042A
-
-
- HY-177641B
-
|
|
Hepcidin
|
Others
|
|
Lexaptepid Pegol sodium scrambled negative control is the sequence scrambled negative control of Lexaptepid Pegol sodium.
|
-
- HY-153480C
-
-
- HY-147079C
-
|
|
Integrin
|
Cardiovascular Disease
|
|
Egaptivon pegol sodium scrambled negative control is the sequence scrambled negative control of Egaptivon pegol sodium.
|
-
- HY-147080B
-
|
|
Complement System
|
Others
|
|
Avacincaptad pegol sodium scrambled negative control is the sequence scrambled negative control of Avacincaptad pegol sodium.
|
-
- HY-158828A
-
|
|
EGFR
|
Cancer
|
|
SSO111 sodium scrambled negative control is the sequence scrambled negative control of SSO111 sodium.
|
-
- HY-177613B
-
|
|
Kinesin
|
Cancer
|
|
ALN-12115 sodium scrambled negative control is the sequence scrambled negative control of ALN-12115 sodium.
|
-
- HY-177614A
-
|
|
VEGFR
|
Cancer
|
|
ALN-3133 sodium scrambled negative control is the sequence scrambled negative control of ALN-3133 sodium.
|
-
- HY-158826B
-
-
- HY-177663A
-
|
|
TMPRSS6
|
Infection
|
|
SARSi-4 sodium scrambled negative control is the sequence scrambled negative control of SARSi-4 sodium.
|
-
- HY-153493C
-
-
- HY-177612B
-
|
|
VEGFR
|
Others
|
|
AGN-745 sodium scrambled negative control is the sequence scrambled negative control of AGN-745 sodium.
|
-
- HY-132600C
-
|
|
MicroRNA
HCV
|
Infection
|
|
RG-101 sodium scrambled negative control is the sequence scrambled negative control of RG-101 sodium.
|
-
- HY-148827C
-
|
|
PKA
|
Cancer
|
|
GEM-231 sodium scrambled negative control is the sequence scrambled negative control of GEM-231 sodium.
|
-
- HY-177636B
-
|
|
17β-HSD
|
Infection
|
|
GPI2A sodium scrambled negative control is the sequence scrambled negative control of GPI2A sodium.
|
-
- HY-147081I
-
-
- HY-P0121A
-
|
|
MDM-2/p53
|
Cancer
|
|
ReACp53 scrambled peptide is a negative control for ReACp53 (HY-P0121). ReACp53 scrambled peptide can be used in the study of ovarian cancer .
|
-
- HY-153845B
-
|
|
Biochemical Assay Reagents
|
Others
|
|
RNA Aptamer Broccoli sodium scrambled negative control is the sequence scrambled negative control of RNA Aptamer Broccoli sodium.
|
-
- HY-153843A
-
-
- HY-160060A
-
|
|
Mucin
|
Cancer
|
|
MA3 aptamer sodium scrambled negative control is the sequence scrambled negative control of MA3 aptamer sodium.
|
-
- HY-P10101
-
|
APTscr
|
STAT
|
Others
|
|
APT STAT3, scrambled (APTscr), a control peptide of STAT3-specific aptide (APTSTAT3), does not bind STAT3. APT STAT3, scrambled contains the same trpzip scaffold but with a scrambled sequence in the target-binding site .
|
-
- HY-148688C
-
|
|
DNA/RNA Synthesis
|
Others
|
|
ASO 556089 sodium scrambled negative control is the sequence scrambled negative control of ASO 556089 sodium.
|
-
- HY-153488C
-
|
|
Ras
|
Cancer
|
|
ISIS 2503 sodium scrambled negative control is the sequence scrambled negative control of ISIS 2503 sodium.
|
-
- HY-153489C
-
-
- HY-153837C
-
|
|
HCV
|
Infection
|
|
ISIS 14803 sodium scrambled negative control is the sequence scrambled negative control of ISIS 14803 sodium.
|
-
- HY-159697B
-
|
|
GHR
|
Others
|
|
ISIS 532401 sodium scrambled negative control is the sequence scrambled negative control of ISIS 532401 sodium.
|
-
- HY-177638B
-
-
- HY-159696B
-
|
|
GCGR
|
Metabolic Disease
|
|
ISIS 449884 sodium scrambled negative control is the sequence scrambled negative control of ISIS 449884 sodium.
|
-
- HY-145726C
-
-
- HY-153490C
-
|
|
Raf
|
Cancer
|
|
ISIS 5132 sodium scrambled negative control is the sequence scrambled negative control of ISIS 5132 sodium.
|
-
- HY-153481C
-
|
|
Integrin
|
Others
|
|
ATL 1102 sodium scrambled negative control is the sequence scrambled negative control of ATL 1102 sodium.
|
-
- HY-148828C
-
|
|
iGluR
|
Neurological Disease
|
|
LSP-GR3 sodium scrambled negative control is the sequence scrambled negative control of LSP-GR3 sodium.
|
-
- HY-160052B
-
|
|
Interleukin Related
|
Cancer
|
|
IL-6 aptamer sodium scrambled negative control is the sequence scrambled negative control of IL-6 aptamer sodium.
|
-
- HY-P1849A
-
|
scJag-1 TFA
|
Notch
|
Cardiovascular Disease
|
|
JAG-1, scrambled (scJag-1) TFA is a scrambled sequence of JAG-1 (Jagged-1 protein). JAG-1, scrambled TFA has a random sequence of the amino acids that are the same as the active fragment. JAG-1, scrambled TFA is usually used as a negative control .
|
-
- HY-P0121B
-
|
|
MDM-2/p53
|
Cancer
|
|
ReACp53 scrambled peptide TFA is a negative control for ReACp53 (HY-P0121). ReACp53 scrambled peptide can be used in the study of ovarian cancer .
|
-
- HY-159694B
-
|
|
Phosphatase
|
Metabolic Disease
|
|
IONIS PTP1BRx sodium scrambled negative control is the sequence scrambled negative control of IONIS PTP1BRx sodium.
|
-
- HY-160066A
-
-
- HY-159698B
-
-
- HY-147425C
-
|
SLN360 sodium scrambled negative control
|
Small Interfering RNA (siRNA)
Apolipoprotein
|
Cardiovascular Disease
Metabolic Disease
|
|
Zerlasiran (SLN360) sodium scrambled negative control is the sequence scrambled negative control of Zerlasiran sodium (HY-147425A). Zerlasiran sodium is a siRNA targeting apolipoprotein A (ApoA). Zerlasiran sodium targets hepatic ApoA synthesis via RNA interference to degrade encoding mRNA. Zerlasiran sodium can be used for the research of atherosclerotic cardiovascular disease and elevated ApoA levels .
|
-
- HY-132582E
-
|
|
Tau Protein
|
Cancer
|
|
Tau ASO-12 (murine) sodium scrambled negative control is the sequence scrambled negative control of Tau ASO-12 (murine) sodium.
|
-
- HY-160062A
-
|
|
Mucin
|
Cancer
|
|
S2.2 aptamer sodium scrambled negative control is the sequence scrambled negative control of S2.2 aptamer sodium.
|
-
- HY-P1908
-
-
- HY-159691B
-
|
|
FGFR
|
Metabolic Disease
|
|
IONIS-FGFR4Rx sodium scrambled negative control is the sequence scrambled negative control of IONIS-FGFR4Rx sodium.
|
-
- HY-P3211B
-
|
LR12-scr
|
TREM receptor
|
Inflammation/Immunology
|
|
Nangibotide scrambled peptide (LR12-scr) is a scrambled control peptide composed of the same amino acids from LR12 (Nangibotide; HY-P3211) but in a random sequence (YQDVELCETGED) .
|
-
- HY-P4106
-
|
|
Amino Acid Derivatives
|
Neurological Disease
|
|
Tat-GluR23Y, scrambled is the scrambled peptide of Tat-GluR23Y (HY-P2259). Tat-GluR23Y is a synthetic peptide containing tyrosine residues that inhibit AMPAR endocytosis and is effective in the research of long-term depression (LTD) .
|
-
- HY-132587C
-
|
|
Small Interfering RNA (siRNA)
Factor Xa
Thrombin
|
Cardiovascular Disease
|
|
Fitusiran sodium scrambled negative control is the sequence scrambled negative control of Fitusiran sodium. Fitusiran (ALN-AT3SC) sodium is a siRNA strategy. Fitusiran delivers siRNA targeting the SERPINC1 gene in hepatocytes to inhibit antithrombin synthesis. Fitusiran sodium enhances thrombin activity and increases Thrombin generation, thereby restoring hemostatic function. Fitusiran sodium can be used in hemophilia-related research .
|
-
- HY-132583D
-
|
|
Dynamin
|
Cardiovascular Disease
|
|
IONIS-DNM2-2.5Rx sodium scrambled negative control is the sequence scrambled negative control of IONIS-DNM2-2.5Rx sodium.
|
-
- HY-P4106A
-
|
|
Amino Acid Derivatives
|
Neurological Disease
|
|
Tat-GluR23Y, scrambled TFA is the scrambled peptide of Tat-GluR23Y (HY-P2259). Tat-GluR23Y is a synthetic peptide containing tyrosine residues that inhibit AMPAR endocytosis and is effective in the research of long-term depression (LTD) .
|
-
- HY-P4867
-
-
- HY-P10116
-
|
APTscr-9R
|
STAT
|
Others
|
|
APTSTAT3-9R, scrambled (APTscr-9R) is a control peptide that forms a structure similar to that of APTSTAT3-9R (HY-P2282) but possesses a scrambled sequence in the target-binding region .
|
-
- HY-132601C
-
|
|
Small Interfering RNA (siRNA)
|
Cancer
|
|
Cobomarsen scrambled control is the negative control form of Cobomarsen (HY-132601), with the sequence: ACAUCAUAGUGACU. The modification method is the same as that of Cobomarsen. Cobomarsen sodium is an oligonucleotide inhibitor of miR-155 and can be used in the research of B-cell lymphoma.
|
-
- HY-P2260B
-
|
|
HIV
|
Infection
|
|
Tat-beclin 1 scrambled is the scrambled part and a scrambled control of Tat-beclin 1 (HY-P2260), which is derived from a region of the autophagy protein, beclin 1. beclin 1 induces autophagy via binding human immunodeficiency virus, HIV-1 Nef and interacting with negative regulator GAPR-1 (GLIPR2). Tat-beclin 1 decreases the accumulation of polyglutamine expansion protein aggregates and the replication of several pathogens, such as HIV-1. Tat-beclin 1 also reduces mortality in mice infected with chikungunya or West Nile virus .
|
-
- HY-P4867A
-
-
- HY-P2260C
-
|
|
HIV
|
Infection
|
|
Tat-beclin 1 scrambled TFA is the scrambled part and a scrambled control of Tat-beclin 1 (HY-P2260), which is derived from a region of the autophagy protein, beclin 1. beclin 1 induces autophagy via binding human immunodeficiency virus, HIV-1 Nef and interacting with negative regulator GAPR-1 (GLIPR2). Tat-beclin 1 decreases the accumulation of polyglutamine expansion protein aggregates and the replication of several pathogens, such as HIV-1. Tat-beclin 1 also reduces mortality in mice infected with chikungunya or West Nile virus .
|
-
- HY-P10638A
-
|
|
CaMK
|
Cardiovascular Disease
Neurological Disease
|
|
TAT-CN21 (scrambled) is a nonsense sequence control peptide fused with the TAT cell-penetrating sequence. It exerts no inhibitory effect on CaMKII activity and serves as a negative control for TatCN21 (HY-P10638) .
|
-
- HY-158821B
-
|
|
TGF-beta/Smad
|
Neurological Disease
|
|
ISTH0036 sodium scrambled negative control is the sequence scrambled negative control of ISTH0036 sodium (HY-158821A). ISTH0036 sodium is a phosphorothioate LNA-modified antisense oligonucleotide gapmer that selectively targets and downregulates TGF-β2 mRNA. ISTH0036 sodium suppresses TGF-β2 expression, reduces choroidal neovascularization and vascular leakage, inhibits fibrosis, blocks epithelial-to-mesenchymal transition, and inhibits angiogenesis while promoting bleb survival. ISTH0036 sodium exhibits long-lasting, dose-dependent ocular tissue distribution and target engagement in rabbit and non-human primate eyes. ISTH0036 sodium can be used for the study of various ocular disorders, such as glaucoma and neovascular retinal diseases.
|
-
- HY-132582D
-
|
IONIS-MAPTRx scramble control
|
Tau Protein
|
Neurological Disease
|
|
Scrambled IONIS-MAPTRx (sodium) is a scrambled sequence of IONIS-MAPTRx sodium (HY-132582C). Scrambled IONIS-MAPTRx (sodium) has the same amino acid composition as the active IONIS-MAPTRx sodium fragment, but the sequence is randomly scrambled. Scrambled IONIS-MAPTRx (sodium) is typically used as a negative control. Scrambled IONIS-MAPTRx (sodium) has potential for studying Alzheimer's disease.
|
-
- HY-P11208B
-
|
|
GABA Receptor
|
Inflammation/Immunology
|
|
mNLS-CPP-scramble (TFA) is the trifluoroacetate salt of mNLS-CPP-scramble (HY-P11208A). mNLS-CPP-scramble is a negative control peptide of mNLS-CPP-WSTF. mNLS-CPP-scramble is promising for research of chronic inflammatory diseases (e.g., MASH, osteoarthritis) .
|
-
- HY-147266C
-
|
|
Small Interfering RNA (siRNA)
|
Infection
|
|
Elebsiran scramble negative control is the scrambled sequence of Elebsiran (HY-147266), and its modification method is the same. Elebsiran scramble negative control can be used as the negative control for Elebsiran.
|
-
- HY-P3816
-
|
|
PKC
|
Others
|
|
PKCε Inhibitor Scramble Peptide is a scrambled peptide with identical amino acid composition to PKCε inhibitor peptide.
|
-
- HY-164970
-
-
- HY-P11208A
-
|
|
GABA Receptor
|
Inflammation/Immunology
|
|
mNLS-CPP-scramble is a negative control peptide of mNLS-CPP-WSTF. mNLS-CPP-scramble is promising for research of chronic inflammatory diseases (e.g., MASH, osteoarthritis) .
|
-
- HY-P11791A
-
-
- HY-P10739D
-
-
- HY-P5384
-
|
|
NADPH Oxidase
|
Others
|
|
sgp91 ds-tat is a biological active peptide. (This is a scrambled control peptide for gp91 ds-tat.)
|
-
- HY-148100C
-
|
|
CCR
|
Inflammation/Immunology
Cancer
|
|
Emapticap pegol scramble negative control, an oligonucleotide aptamer, is the negative control of Emapticap pegol (HY-148100) .
|
-
- HY-P3395A
-
|
|
PERK
JNK
p38 MAPK
|
Inflammation/Immunology
|
|
Catestatin sCst is a negative control peptide with a scrambled amino acid sequence. Catestatin sCst fails to activate human mast cells and is used to verify the specificity of Catestatin action .
|
-
- HY-P10739E
-
|
|
|
Others
|
|
YRLGRWC is a scrambled control of WYRGRLC (HY-P10739C), and it is synthesized by conjugating cysteine to the carboxyl (C-terminus) of YRLGRW (HY-P10739D) .
|
-
- HY-145727C
-
|
ISIS 304801 scramble negative control
|
Apolipoprotein
|
Endocrinology
|
|
Volanesorsen scramble negative control is a negative control for volanesorsen (HY-145727) with the sequence: CAUGUTCUTCUGCATGUCAU. Volanesorsen (ISIS 304801) is an antisense oligonucleotide inhibitor of apolipoprotein CIII (apo-CIII) mRNA that can lower triglyceride levels and improve insulin resistance .
|
-
- HY-P10169
-
|
|
Proteasome
|
Others
|
|
Acetyl-Calpastatin(184-210)(human), Negative Control is a control scramble peptide of Acetyl-Calpastatin(184-210)(human) (HY-P1081). Acetyl-Calpastatin(184-210)(human) is a potent, selective and reversible calpain inhibitor .
|
-
- HY-116748
-
|
|
PDI
Phosphatase
|
|
|
(±)-trans-1,2-Bis(2-mercaptoacetamido)cyclohexane is a small-molecule dithiol catalyst with a low thiol pKa value (8.3) and high reduction potential (-0.24 V), capable of mimicking PDI activity. It catalyzes the activation of scrambled ribonuclease A (scrambled ribonuclease A) and promotes the formation of native disulfide bonds, thereby significantly enhancing protein folding efficiency. Adding (±)-trans-1,2-Bis(2-mercaptoacetamido)cyclohexane to the culture medium of Saccharomyces cerevisiae can increase the secretion of exogenously expressed Schizosaccharomyces pombe acid phosphatase by more than threefold. (±)-trans-1,2-Bis(2-mercaptoacetamido)cyclohexane holds great potential for applications in protein production and secretion research .
|
-
| Cat. No. |
Product Name |
Target |
Research Area |
-
- HY-P3211B
-
|
LR12-scr
|
TREM receptor
|
Inflammation/Immunology
|
|
Nangibotide scrambled peptide (LR12-scr) is a scrambled control peptide composed of the same amino acids from LR12 (Nangibotide; HY-P3211) but in a random sequence (YQDVELCETGED) .
|
-
- HY-P1513A
-
|
|
Bacterial
|
Infection
|
|
LL-37 scrambled peptide acetate is a scrambled version of cathelicidin anti-microbial peptide LL-37. LL-37 scrambled peptide acetate can be used as a negative control of LL-37 peptide studies.
|
-
- HY-P2260B
-
|
|
HIV
|
Infection
|
|
Tat-beclin 1 scrambled is the scrambled part and a scrambled control of Tat-beclin 1 (HY-P2260), which is derived from a region of the autophagy protein, beclin 1. beclin 1 induces autophagy via binding human immunodeficiency virus, HIV-1 Nef and interacting with negative regulator GAPR-1 (GLIPR2). Tat-beclin 1 decreases the accumulation of polyglutamine expansion protein aggregates and the replication of several pathogens, such as HIV-1. Tat-beclin 1 also reduces mortality in mice infected with chikungunya or West Nile virus .
|
-
- HY-P4867A
-
-
- HY-P10776
-
|
|
Peptides
|
Others
|
|
RNS peptide is a randomly scrambled control peptide that can be used as a negative control for MANS peptide (HY-P10218) .
|
-
- HY-P0121B
-
|
|
MDM-2/p53
|
Cancer
|
|
ReACp53 scrambled peptide TFA is a negative control for ReACp53 (HY-P0121). ReACp53 scrambled peptide can be used in the study of ovarian cancer .
|
-
- HY-P5400
-
|
|
Peptides
|
Others
|
|
OVA (257-264), scrambled is a biological active peptide. (Out-of-order control peptide of HY-P1489)
|
-
- HY-P1513
-
|
|
Bacterial
|
Infection
|
|
LL-37 scrambled peptide is a scrambled version of cathelicidin anti-microbial peptide LL-37. LL-37 scrambled peptide can be used as a negative control of LL-37 peptide studies.
|
-
- HY-P1849A
-
|
scJag-1 TFA
|
Notch
|
Cardiovascular Disease
|
|
JAG-1, scrambled (scJag-1) TFA is a scrambled sequence of JAG-1 (Jagged-1 protein). JAG-1, scrambled TFA has a random sequence of the amino acids that are the same as the active fragment. JAG-1, scrambled TFA is usually used as a negative control .
|
-
- HY-P4867
-
-
- HY-P2260C
-
|
|
HIV
|
Infection
|
|
Tat-beclin 1 scrambled TFA is the scrambled part and a scrambled control of Tat-beclin 1 (HY-P2260), which is derived from a region of the autophagy protein, beclin 1. beclin 1 induces autophagy via binding human immunodeficiency virus, HIV-1 Nef and interacting with negative regulator GAPR-1 (GLIPR2). Tat-beclin 1 decreases the accumulation of polyglutamine expansion protein aggregates and the replication of several pathogens, such as HIV-1. Tat-beclin 1 also reduces mortality in mice infected with chikungunya or West Nile virus .
|
-
- HY-P10638A
-
|
|
CaMK
|
Cardiovascular Disease
Neurological Disease
|
|
TAT-CN21 (scrambled) is a nonsense sequence control peptide fused with the TAT cell-penetrating sequence. It exerts no inhibitory effect on CaMKII activity and serves as a negative control for TatCN21 (HY-P10638) .
|
-
- HY-P11208B
-
|
|
GABA Receptor
|
Inflammation/Immunology
|
|
mNLS-CPP-scramble (TFA) is the trifluoroacetate salt of mNLS-CPP-scramble (HY-P11208A). mNLS-CPP-scramble is a negative control peptide of mNLS-CPP-WSTF. mNLS-CPP-scramble is promising for research of chronic inflammatory diseases (e.g., MASH, osteoarthritis) .
|
-
- HY-P3816
-
|
|
PKC
|
Others
|
|
PKCε Inhibitor Scramble Peptide is a scrambled peptide with identical amino acid composition to PKCε inhibitor peptide.
|
-
- HY-P11208A
-
|
|
GABA Receptor
|
Inflammation/Immunology
|
|
mNLS-CPP-scramble is a negative control peptide of mNLS-CPP-WSTF. mNLS-CPP-scramble is promising for research of chronic inflammatory diseases (e.g., MASH, osteoarthritis) .
|
-
- HY-P0121A
-
|
|
MDM-2/p53
|
Cancer
|
|
ReACp53 scrambled peptide is a negative control for ReACp53 (HY-P0121). ReACp53 scrambled peptide can be used in the study of ovarian cancer .
|
-
- HY-P1138
-
|
FSVYWAQADR
|
Gap Junction Protein
|
Others
|
|
Scrambled 10Panx (FSVYWAQADR) is a random sequence variant of a specific inhibitory peptide 10Panx targeted at the half-channel of Pannexin-1 (Panx1). Scrambled 10Panx is used as a control peptide to determine whether other experimental conditions or peptides act through specific molecular mechanisms. Scrambled 10Panx can be used for research in neurobiology and cell biology .
|
-
- HY-P5121B
-
|
|
Peptides
|
Cardiovascular Disease
|
|
γ-Fibrinogen 377-395 scrambled TFA is a control peptide that forms a structure similar to that of γ-Fibrinogen 377-395 TFA (HY-P5121A) but possesses a scrambled sequence in the target-binding region.
|
-
- HY-P5500
-
|
|
Peptides
|
Others
|
|
Peptide P1 is a biological active peptide. (commonly used to measure the degree of scrambling during ETD analysis)
|
-
- HY-P10169
-
|
|
Proteasome
|
Others
|
|
Acetyl-Calpastatin(184-210)(human), Negative Control is a control scramble peptide of Acetyl-Calpastatin(184-210)(human) (HY-P1081). Acetyl-Calpastatin(184-210)(human) is a potent, selective and reversible calpain inhibitor .
|
-
- HY-P2517
-
|
|
Peptides
|
Others
|
|
Scrambled TRAP Fragment is a scrambled sequence of TRAP Fragment. Scrambled TRAP Fragment with a random sequence of the amino acids that are the same as the active fragment. Scrambled TRAP Fragment usually used as a negative control.
|
-
- HY-P1391
-
|
|
iGluR
|
Others
|
|
ZIP(Scrambled) is a scrambled control peptide for zeta inhibitory peptide (ZIP) .
|
-
- HY-P1400
-
-
- HY-P1391A
-
|
|
PKC
|
Others
|
|
ZIP(Scrambled) TFA is a scrambled control peptide for zeta inhibitory peptide (ZIP) .
|
-
- HY-P1849
-
|
scJag-1
|
Peptides
|
Cardiovascular Disease
|
|
JAG-1, scrambled (scJag-1) is a scrambled sequence of JAG-1 (Jagged-1 protein). JAG-1, scrambled has a random sequence of the amino acids that are the same as the active fragment. JAG-1, scrambled is usually used as a negative control .
|
-
- HY-P10101
-
|
APTscr
|
STAT
|
Others
|
|
APT STAT3, scrambled (APTscr), a control peptide of STAT3-specific aptide (APTSTAT3), does not bind STAT3. APT STAT3, scrambled contains the same trpzip scaffold but with a scrambled sequence in the target-binding site .
|
-
- HY-P1908
-
-
- HY-P4112
-
|
|
Peptides
|
Others
|
|
TAT-NSF222scr Fusion Polypeptide, scrambled is a control peptide of TAT-NSF700 Fusion Peptide (HY-P4113). TAT-NSF222scr Fusion Polypeptide, scrambled is consisted of the intact TAT domain followed by the amino acid residues of NSF 222-243 in a scrambled order .
|
-
- HY-P4106
-
|
|
Amino Acid Derivatives
|
Neurological Disease
|
|
Tat-GluR23Y, scrambled is the scrambled peptide of Tat-GluR23Y (HY-P2259). Tat-GluR23Y is a synthetic peptide containing tyrosine residues that inhibit AMPAR endocytosis and is effective in the research of long-term depression (LTD) .
|
-
- HY-P4106A
-
|
|
Amino Acid Derivatives
|
Neurological Disease
|
|
Tat-GluR23Y, scrambled TFA is the scrambled peptide of Tat-GluR23Y (HY-P2259). Tat-GluR23Y is a synthetic peptide containing tyrosine residues that inhibit AMPAR endocytosis and is effective in the research of long-term depression (LTD) .
|
-
- HY-P5370
-
|
|
Amyloid-β
|
Others
|
|
Scrambled β-amyloid (1-40) is a biological active peptide. (Aβ (1-40) together with Aβ (1-42) are two major C-terminal variants of the Aβ protein constituting the majority of Aβs. These undergo post-secretory aggregation and deposition in the Alzheimer’s disease brain. This peptide is the scrambled sequence of Abeta 1-40 HY-P0265)
|
-
- HY-P10116
-
|
APTscr-9R
|
STAT
|
Others
|
|
APTSTAT3-9R, scrambled (APTscr-9R) is a control peptide that forms a structure similar to that of APTSTAT3-9R (HY-P2282) but possesses a scrambled sequence in the target-binding region .
|
-
- HY-P4734
-
|
|
Peptides
|
Others
|
|
5-FAM-LL-37 (scrambled) is a polypeptide that can be found by peptide screening. Peptide screening is a research tool that pools active peptides primarily by immunoassay. Peptide screening can be used for protein interaction, functional analysis, epitope screening, especially in the field of agent research and development .
|
-
- HY-P5384
-
|
|
NADPH Oxidase
|
Others
|
|
sgp91 ds-tat is a biological active peptide. (This is a scrambled control peptide for gp91 ds-tat.)
|
-
- HY-P4749
-
|
|
Peptides
|
Neurological Disease
|
|
Prion Protein (106-126) (human) (scrambled) is a scrambled sequence of Prion Protein (106-126). Prion Protein (106-126) (human) (scrambled) with a random sequence of the amino acids that are the same as the active fragment. Prion Protein (106-126) (human) (scrambled) usually used as a negative control .
|
-
- HY-P10186
-
-
- HY-P11791A
-
-
- HY-P10739D
-
-
- HY-P4096B
-
|
|
Peptides
|
Inflammation/Immunology
|
|
scHAP-1 is a scrambled HAP-1 peptide, and HAP-1 is a synovial homing peptide. After amino acid sequence scrambling, scHAP-1 still specifically binds to human and rabbit fibroblast-like synoviocytes (FLS), while showing extremely weak binding to human umbilical vein endothelial cells, which proves that it remains an effective FLS-targeting ligand. scHAP-1 can be used in studies related to rheumatoid arthritis .
|
-
- HY-P3395A
-
|
|
PERK
JNK
p38 MAPK
|
Inflammation/Immunology
|
|
Catestatin sCst is a negative control peptide with a scrambled amino acid sequence. Catestatin sCst fails to activate human mast cells and is used to verify the specificity of Catestatin action .
|
-
- HY-P10739E
-
|
|
|
Others
|
|
YRLGRWC is a scrambled control of WYRGRLC (HY-P10739C), and it is synthesized by conjugating cysteine to the carboxyl (C-terminus) of YRLGRW (HY-P10739D) .
|
| Cat. No. |
Product Name |
Target |
Research Area |
Image |
| Cat. No. |
Product Name |
|
Classification |
- HY-153485C
-
|
|
|
Antisense Oligonucleotides
|
|
Cimdelirsen sodium scrambled negative control is the sequence scrambled negative control of Cimdelirsen sodium.
|
- HY-177620B
-
|
|
|
Antisense Oligonucleotides
|
|
Cadapersen sodium scrambled negative control is the sequence scrambled negative control of Cadapersen sodium.
|
- HY-145725D
-
|
|
|
Antisense Oligonucleotides
|
|
Baliforsen sodium scrambled negative control is the sequence scrambled negative control of Baliforsen sodium.
|
- HY-149906D
-
|
|
|
Antisense Oligonucleotides
|
|
Trecovirsen sodium scrambled negative control is the sequence scrambled negative control of Trecovirsen sodium.
|
- HY-177656B
-
|
|
|
siRNAs
siRNA drugs
|
|
Pivicasiran sodium scrambled negative control is the sequence scrambled negative control of Pivicasiran sodium.
|
- HY-147262A
-
|
|
|
siRNAs
siRNA drugs
|
|
Etedesiran scrambled negative control is the sequence scrambled negative control of Etedesiran.
|
- HY-P3392C
-
|
|
|
Antisense Oligonucleotides
|
|
Zilganersen sodium scrambled negative control is the sequence scrambled negative control of Zilganersen sodium.
|
- HY-177619B
-
|
|
|
siRNAs
siRNA drugs
|
|
Belcesiran sodium scrambled negative control is the sequence scrambled negative control of Belcesiran sodium.
|
- HY-153483C
-
|
|
|
siRNAs
siRNA drugs
|
|
Bamosiran sodium scrambled negative control is the sequence scrambled negative control of Bamosiran sodium.
|
- HY-132586C
-
|
|
|
Antisense Oligonucleotides
|
|
Viltolarsen sodium scrambled negative control is the sequence scrambled negative control of Viltolarsen sodium.
|
- HY-132613A
-
|
|
|
siRNAs
siRNA drugs
|
|
Lumasiran sodium scrambled negative control is the sequence scrambled negative control of Lumasiran sodium.
|
- HY-177658B
-
|
|
|
Antisense Oligonucleotides
|
|
Renadirsen sodium scrambled negative control is the sequence scrambled negative control of Renadirsen sodium.
|
- HY-177622B
-
|
|
|
Antisense Oligonucleotides
|
|
Cibrigirsen sodium scrambled negative control is the sequence scrambled negative control of Cibrigirsen sodium.
|
- HY-148130C
-
|
|
|
Antisense Oligonucleotides
|
|
Rugonersen sodium scrambled negative control is the sequence scrambled negative control of Rugonersen sodium.
|
- HY-145721C
-
|
|
|
Antisense Oligonucleotides
|
|
Mongersen sodium scrambled negative control is the sequence scrambled negative control of Mongersen sodium.
|
- HY-177661B
-
|
|
|
Antisense Oligonucleotides
|
|
Salanersen sodium scrambled negative control is the sequence scrambled negative control of Salanersen sodium.
|
- HY-132611C
-
|
|
|
Antisense Oligonucleotides
|
|
Golodirsen sodium scrambled negative control is the sequence scrambled negative control of Golodirsen sodium.
|
- HY-177652B
-
|
|
|
siRNAs
siRNA drugs
|
|
Onvuzosiran sodium scrambled negative control is the sequence scrambled negative control of Onvuzosiran sodium.
|
- HY-147412C
-
|
|
|
Antisense Oligonucleotides
|
|
Ultevursen sodium scrambled negative control is the sequence scrambled negative control of Ultevursen sodium.
|
- HY-142118C
-
|
|
|
Antisense Oligonucleotides
|
|
Trabedersen sodium scrambled negative control is the sequence scrambled negative control of Trabedersen sodium.
|
- HY-132591C
-
|
|
|
siRNAs
siRNA drugs
|
|
Inclisiran sodium scrambled negative control is the sequence scrambled negative control of Inclisiran sodium.
|
- HY-132608A
-
|
|
|
Antisense Oligonucleotides
|
|
Inotersen sodium scrambled negative control is the sequence scrambled negative control of Inotersen sodium.
|
- HY-132610E
-
|
|
|
siRNAs
siRNA drugs
|
|
Givosiran sodium scrambled negative control is the sequence scrambled negative control of Givosiran sodium.
|
- HY-177671B
-
|
|
|
siRNAs
siRNA drugs
|
|
Zodasiran sodium scrambled negative control is the sequence scrambled negative control of Zodasiran sodium.
|
- HY-109528A
-
|
|
|
Antisense Oligonucleotides
|
|
Fomivirsen sodium scrambled negative control is the sequence scrambled negative control of Fomivirsen sodium.
|
- HY-177971A
-
|
|
|
siRNAs
|
|
Braxlosiran scrambled negative control is the sequence scrambled negative control of Braxlosiran.
|
- HY-148089C
-
|
|
|
Antisense Oligonucleotides
|
|
Eplontersen sodium scrambled negative control is the sequence scrambled negative control of Eplontersen sodium.
|
- HY-177664B
-
|
|
|
siRNAs
siRNA drugs
|
|
Senvesiran sodium scrambled negative control is the sequence scrambled negative control of Senvesiran sodium.
|
- HY-148413A
-
|
|
|
Antisense Oligonucleotides
|
|
Aprinocarsen sodium scrambled negative control is the sequence scrambled negative control of Aprinocarsen sodium.
|
- HY-177643B
-
|
|
|
siRNAs
siRNA drugs
|
|
Lixadesiran sodium scrambled negative control is the sequence scrambled negative control of Lixadesiran sodium.
|
- HY-164419B
-
|
|
|
Antisense Oligonucleotides
|
|
Atesidorsen sodium scrambled negative control is the sequence scrambled negative control of Atesidorsen sodium.
|
- HY-118874C
-
|
|
|
Antisense Oligonucleotides
|
|
Oblimersen sodium scrambled negative control is the sequence scrambled negative control of Oblimersen sodium.
|
- HY-153497C
-
|
|
|
Antisense Oligonucleotides
|
|
Vupanorsen sodium scrambled negative control is the sequence scrambled negative control of Vupanorsen sodium.
|
- HY-177669B
-
|
|
|
siRNAs
siRNA drugs
|
|
Vortosiran sodium scrambled negative control is the sequence scrambled negative control of Vortosiran sodium.
|
- HY-177666B
-
|
|
|
siRNAs
siRNA drugs
|
|
Solbinsiran sodium scrambled negative control is the sequence scrambled negative control of Solbinsiran sodium.
|
- HY-177629B
-
|
|
|
Antisense Oligonucleotides
|
|
Elsunersen sodium scrambled negative control is the sequence scrambled negative control of Elsunersen sodium.
|
- HY-177672B
-
|
|
|
siRNAs
siRNA drugs
|
|
Zotresiran sodium scrambled negative control is the sequence scrambled negative control of Zotresiran sodium.
|
- HY-151123C
-
|
|
|
Antisense Oligonucleotides
|
|
Pelacarsen sodium scrambled negative control is the sequence scrambled negative control of Pelacarsen sodium.
|
- HY-112980C
-
|
|
|
Antisense Oligonucleotides
|
|
Nusinersen sodium scrambled negative control is the sequence scrambled negative control of Nusinersen sodium.
|
- HY-145722D
-
|
|
|
Antisense Oligonucleotides
|
|
Apatorsen sodium scrambled negative control is the sequence scrambled negative control of Apatorsen sodium.
|
- HY-147426C
-
|
|
|
siRNAs
siRNA drugs
|
|
Zifcasiran sodium scrambled negative control is the sequence scrambled negative control of Zifcasiran sodium.
|
- HY-177644B
-
|
|
|
Antisense Oligonucleotides
|
|
Lufepirsen sodium scrambled negative control is the sequence scrambled negative control of Lufepirsen sodium.
|
- HY-145728D
-
|
|
|
Antisense Oligonucleotides
|
|
Alicaforsen sodium scrambled negative control is the sequence scrambled negative control of Alicaforsen sodium.
|
- HY-177611B
-
|
|
|
siRNAs
siRNA drugs
|
|
Agazisiran sodium scrambled negative control is the sequence scrambled negative control of Agazisiran sodium.
|
- HY-177653B
-
|
|
|
Antisense Oligonucleotides
|
|
Opemalirsen sodium scrambled negative control is the sequence scrambled negative control of Opemalirsen sodium.
|
- HY-150212C
-
|
|
|
Antisense Oligonucleotides
|
|
Tilsotolimod sodium scrambled negative control is the sequence scrambled negative control of Tilsotolimod sodium.
|
- HY-132580D
-
|
|
|
Antisense Oligonucleotides
|
|
Tofersen sodium scrambled negative control is the sequence scrambled negative control of Tofersen sodium.
|
- HY-177659B
-
|
|
|
Antisense Oligonucleotides
|
|
Rimigorsen sodium scrambled negative control is the sequence scrambled negative control of Rimigorsen sodium.
|
- HY-177616B
-
|
|
|
Antisense Oligonucleotides
|
|
Archexin sodium scrambled negative control is the sequence scrambled negative control of Archexin sodium.
|
- HY-177615B
-
|
|
|
Antisense Oligonucleotides
|
|
Apazunersen sodium scrambled negative control is the sequence scrambled negative control of Apazunersen sodium.
|
- HY-158820B
-
|
|
|
siRNAs
siRNA drugs
|
|
Cosdosiran sodium scrambled negative control is the sequence scrambled negative control of Cosdosiran sodium.
|
- HY-147267C
-
|
|
|
Antisense Oligonucleotides
|
|
Evazarsen sodium scrambled negative control is the sequence scrambled negative control of Evazarsen sodium.
|
- HY-153479C
-
|
|
|
Antisense Oligonucleotides
|
|
Aganirsen sodium scrambled negative control is the sequence scrambled negative control of Aganirsen sodium.
|
- HY-164221B
-
|
|
|
siRNAs
siRNA drugs
|
|
Rapirosiran sodium scrambled negative control is the sequence scrambled negative control of Rapirosiran sodium.
|
- HY-164740B
-
|
|
|
siRNAs
siRNA drugs
|
|
Plozasiran sodium scrambled negative control is the sequence scrambled negative control of Plozasiran sodium.
|
- HY-177631B
-
|
|
|
Antisense Oligonucleotides
|
|
Etidaligide sodium scrambled negative control is the sequence scrambled negative control of Etidaligide sodium.
|
- HY-160040B
-
|
|
|
Antisense Oligonucleotides
|
|
Cobitolimod sodium scrambled negative control is the sequence scrambled negative control of Cobitolimod sodium.
|
- HY-132585C
-
|
|
|
Antisense Oligonucleotides
|
|
Vesleteplirsen sodium scrambled negative control is the sequence scrambled negative control of Vesleteplirsen sodium.
|
- HY-177634B
-
|
|
|
siRNAs
siRNA drugs
|
|
Gatuzosiran sodium scrambled negative control is the sequence scrambled negative control of Gatuzosiran sodium.
|
- HY-153484C
-
|
|
|
siRNAs
siRNA drugs
|
|
Bevasiranib sodium scrambled negative control is the sequence scrambled negative control of Bevasiranib sodium.
|
- HY-132589C
-
|
|
|
siRNAs
siRNA drugs
|
|
Vutrisiran sodium scrambled negative control is the sequence scrambled negative control of Vutrisiran sodium.
|
- HY-153492C
-
|
|
|
siRNAs
siRNA drugs
|
|
Olpasiran sodium scrambled negative control is the sequence scrambled negative control of Olpasiran sodium.
|
- HY-158825A
-
|
|
|
Antisense Oligonucleotides
|
|
Cepadacursen sodium scrambled negative control is the sequence scrambled negative control of Cepadacursen sodium.
|
- HY-132604C
-
|
|
|
siRNAs
siRNA drugs
|
|
Fazirsiran sodium scrambled negative control is the sequence scrambled negative control of Fazirsiran sodium.
|
- HY-139786C
-
|
|
|
Antisense Oligonucleotides
|
|
Cofirasersen sodium scrambled negative control is the sequence scrambled negative control of Cofirasersen sodium.
|
- HY-147253C
-
|
|
|
Antisense Oligonucleotides
|
|
Brogidirsen sodium scrambled negative control is the sequence scrambled negative control of Brogidirsen sodium.
|
- HY-153491B
-
|
|
|
Antisense Oligonucleotides
|
|
Olezarsen sodium scrambled negative control is the sequence scrambled negative control of Olezarsen sodium.
|
- HY-177610B
-
|
|
|
Antisense Oligonucleotides
|
|
Afovirsen sodium scrambled negative control is the sequence scrambled negative control of Afovirsen sodium.
|
- HY-108764B
-
|
|
|
Antisense Oligonucleotides
|
|
Mipomersen sodium scrambled negative control is the sequence scrambled negative control of Mipomersen sodium.
|
- HY-145724C
-
|
|
|
Antisense Oligonucleotides
|
|
Drisapersen sodium scrambled negative control is the sequence scrambled negative control of Drisapersen sodium.
|
- HY-147406C
-
|
|
|
Antisense Oligonucleotides
|
|
Tonlamarsen sodium scrambled negative control is the sequence scrambled negative control of Tonlamarsen sodium.
|
- HY-109561A
-
|
|
|
Aptamers
|
|
Pegaptanib sodium scrambled negative control is the sequence scrambled negative control of Pegaptanib sodium.
|
- HY-148370C
-
|
|
|
Antisense Oligonucleotides
|
|
Sefaxersen sodium scrambled negative control is the sequence scrambled negative control of Sefaxersen sodium.
|
- HY-177621B
-
|
|
|
siRNAs
siRNA drugs
|
|
Cevolisiran sodium scrambled negative control is the sequence scrambled negative control of Cevolisiran sodium.
|
- HY-147410C
-
|
|
|
Antisense Oligonucleotides
|
|
Ulefnersen sodium scrambled negative control is the sequence scrambled negative control of Ulefnersen sodium.
|
- HY-139787C
-
|
|
|
Antisense Oligonucleotides
|
|
Donidalorsen sodium scrambled negative control is the sequence scrambled negative control of Donidalorsen sodium (HY-139787A).
|
- HY-156501C
-
|
|
|
Aptamers
|
|
BT101 sodium scrambled negative control is the sequence scrambled negative control of BT101 sodium.
|
- HY-139290C
-
|
|
|
Antisense Oligonucleotides
|
|
RGLS4326 sodium scrambled negative control is the sequence scrambled negative control of RGLS4326 sodium.
|
- HY-148687C
-
|
|
|
Antisense Oligonucleotides
|
|
SPC5001 sodium scrambled negative control is the sequence scrambled negative control of SPC5001 sodium.
|
- HY-153482C
-
|
|
|
siRNAs
siRNA drugs
|
|
ATU027 sodium scrambled negative control is the sequence scrambled negative control of ATU027 sodium.
|
- HY-148689C
-
|
|
|
Antisense Oligonucleotides
|
|
SPC4061 sodium scrambled negative control is the sequence scrambled negative control of SPC4061 sodium.
|
- HY-153999C
-
|
|
|
Aptamers
|
|
Rondaptivon pegol sodium scrambled negative control is the sequence scrambled negative control of Rondaptivon pegol sodium.
|
- HY-158829A
-
- HY-160041B
-
|
|
|
Antisense Oligonucleotides
|
|
Olaptesed pegol sodium scrambled negative control is the sequence scrambled negative control of Olaptesed pegol sodium.
|
- HY-177635B
-
|
|
|
Antisense Oligonucleotides
|
|
GNKG168 sodium scrambled negative control is the sequence scrambled negative control of GNKG168 sodium.
|
- HY-159692C
-
|
|
|
Antisense Oligonucleotides
|
|
AZD8701 sodium scrambled negative control is the sequence scrambled negative control of AZD8701 sodium.
|
- HY-158827B
-
|
|
|
Antisense Oligonucleotides
|
|
AZD8233 sodium scrambled negative control is the sequence scrambled negative control of AZD8233 sodium.
|
- HY-153324C
-
- HY-159695B
-
|
|
|
Antisense Oligonucleotides
|
|
IONIS-GCCRRx sodium scrambled negative control is the sequence scrambled negative control of IONIS-GCCRRx sodium.
|
- HY-160042A
-
|
|
|
Aptamers
|
|
AFP aptamer sodium scrambled negative control is the sequence scrambled negative control of AFP aptamer sodium.
|
- HY-177641B
-
|
|
|
Antisense Oligonucleotides
|
|
Lexaptepid Pegol sodium scrambled negative control is the sequence scrambled negative control of Lexaptepid Pegol sodium.
|
- HY-153480C
-
|
|
|
Aptamers
|
|
ARC19499 sodium scrambled negative control is the sequence scrambled negative control of ARC19499 sodium.
|
- HY-147079C
-
|
|
|
Aptamers
|
|
Egaptivon pegol sodium scrambled negative control is the sequence scrambled negative control of Egaptivon pegol sodium.
|
- HY-147080B
-
|
|
|
Aptamers
|
|
Avacincaptad pegol sodium scrambled negative control is the sequence scrambled negative control of Avacincaptad pegol sodium.
|
- HY-158828A
-
- HY-177613B
-
|
|
|
siRNAs
siRNA drugs
|
|
ALN-12115 sodium scrambled negative control is the sequence scrambled negative control of ALN-12115 sodium.
|
- HY-177614A
-
|
|
|
siRNAs
siRNA drugs
|
|
ALN-3133 sodium scrambled negative control is the sequence scrambled negative control of ALN-3133 sodium.
|
- HY-158826B
-
|
|
|
Antisense Oligonucleotides
|
|
EZN-2968 sodium scrambled negative control is the sequence scrambled negative control of EZN-2968 sodium.
|
- HY-177663A
-
|
|
|
siRNAs
siRNA drugs
|
|
SARSi-4 sodium scrambled negative control is the sequence scrambled negative control of SARSi-4 sodium.
|
- HY-153493C
-
|
|
|
siRNAs
siRNA drugs
|
|
PF-04523655 sodium scrambled negative control is the sequence scrambled negative control of PF-04523655 sodium.
|
- HY-177612B
-
|
|
|
siRNAs
siRNA drugs
|
|
AGN-745 sodium scrambled negative control is the sequence scrambled negative control of AGN-745 sodium.
|
- HY-132600C
-
- HY-158823B
-
|
|
|
Antisense Oligonucleotides
|
|
GTI-2501 sodium scrambled negative control is the sequence scrambled negative control of GTI-2501 sodium.
|
- HY-148827C
-
|
|
|
Antisense Oligonucleotides
|
|
GEM-231 sodium scrambled negative control is the sequence scrambled negative control of GEM-231 sodium.
|
- HY-177636B
-
- HY-147081I
-
|
|
|
Aptamers
|
|
AS 1411 sodium scrambled negative control is the sequence scrambled negative control of AS 1411 sodium.
|
- HY-153845B
-
|
|
|
Aptamers
|
|
RNA Aptamer Broccoli sodium scrambled negative control is the sequence scrambled negative control of RNA Aptamer Broccoli sodium.
|
- HY-153843A
-
|
|
|
Aptamers
|
|
RNA Aptamer Corn sodium scrambled negative control is the sequence scrambled negative control of RNA Aptamer Corn sodium.
|
- HY-160060A
-
|
|
|
Aptamers
|
|
MA3 aptamer sodium scrambled negative control is the sequence scrambled negative control of MA3 aptamer sodium.
|
- HY-148688C
-
|
|
|
Antisense Oligonucleotides
|
|
ASO 556089 sodium scrambled negative control is the sequence scrambled negative control of ASO 556089 sodium.
|
- HY-159693B
-
|
|
|
Antisense Oligonucleotides
|
|
ISIS 626112 sodium scrambled negative control is the sequence scrambled negative control of ISIS 626112 sodium.
|
- HY-153488C
-
|
|
|
Antisense Oligonucleotides
|
|
ISIS 2503 sodium scrambled negative control is the sequence scrambled negative control of ISIS 2503 sodium.
|
- HY-153489C
-
|
|
|
Antisense Oligonucleotides
|
|
ISIS 329993 sodium scrambled negative control is the sequence scrambled negative control of ISIS 329993 sodium.
|
- HY-153837C
-
|
|
|
Antisense Oligonucleotides
|
|
ISIS 14803 sodium scrambled negative control is the sequence scrambled negative control of ISIS 14803 sodium.
|
- HY-159697B
-
|
|
|
Antisense Oligonucleotides
|
|
ISIS 532401 sodium scrambled negative control is the sequence scrambled negative control of ISIS 532401 sodium.
|
- HY-177638B
-
|
|
|
Antisense Oligonucleotides
|
|
ISIS 1082 sodium scrambled negative control is the sequence scrambled negative control of ISIS 1082 sodium.
|
- HY-159696B
-
|
|
|
Antisense Oligonucleotides
|
|
ISIS 449884 sodium scrambled negative control is the sequence scrambled negative control of ISIS 449884 sodium.
|
- HY-145726C
-
|
|
|
Antisense Oligonucleotides
|
|
ISIS 104838 sodium scrambled negative control is the sequence scrambled negative control of ISIS 104838 sodium.
|
- HY-153490C
-
|
|
|
Antisense Oligonucleotides
|
|
ISIS 5132 sodium scrambled negative control is the sequence scrambled negative control of ISIS 5132 sodium.
|
- HY-153481C
-
|
|
|
Antisense Oligonucleotides
|
|
ATL 1102 sodium scrambled negative control is the sequence scrambled negative control of ATL 1102 sodium.
|
- HY-148828C
-
|
|
|
Antisense Oligonucleotides
|
|
LSP-GR3 sodium scrambled negative control is the sequence scrambled negative control of LSP-GR3 sodium.
|
- HY-160052B
-
|
|
|
Aptamers
|
|
IL-6 aptamer sodium scrambled negative control is the sequence scrambled negative control of IL-6 aptamer sodium.
|
- HY-159694B
-
|
|
|
Antisense Oligonucleotides
|
|
IONIS PTP1BRx sodium scrambled negative control is the sequence scrambled negative control of IONIS PTP1BRx sodium.
|
- HY-160066A
-
|
|
|
Aptamers
|
|
SYL3C aptamer sodium scrambled negative control is the sequence scrambled negative control of SYL3C aptamer sodium.
|
- HY-159698B
-
|
|
|
Antisense Oligonucleotides
|
|
IONIS-DGAT 2Rx sodium scrambled negative control is the sequence scrambled negative control of IONIS-DGAT 2Rx sodium.
|
- HY-147425C
-
|
SLN360 sodium scrambled negative control
|
|
siRNAs
siRNA drugs
|
|
Zerlasiran (SLN360) sodium scrambled negative control is the sequence scrambled negative control of Zerlasiran sodium (HY-147425A). Zerlasiran sodium is a siRNA targeting apolipoprotein A (ApoA). Zerlasiran sodium targets hepatic ApoA synthesis via RNA interference to degrade encoding mRNA. Zerlasiran sodium can be used for the research of atherosclerotic cardiovascular disease and elevated ApoA levels .
|
- HY-132582E
-
|
|
|
Antisense Oligonucleotides
|
|
Tau ASO-12 (murine) sodium scrambled negative control is the sequence scrambled negative control of Tau ASO-12 (murine) sodium.
|
- HY-160062A
-
|
|
|
Aptamers
|
|
S2.2 aptamer sodium scrambled negative control is the sequence scrambled negative control of S2.2 aptamer sodium.
|
- HY-158830A
-
|
|
|
Antisense Oligonucleotides
|
|
MDM4-targeting ASO sodium scrambled negative control is the sequence scrambled negative control of MDM4-targeting ASO sodium.
|
- HY-159691B
-
|
|
|
Antisense Oligonucleotides
|
|
IONIS-FGFR4Rx sodium scrambled negative control is the sequence scrambled negative control of IONIS-FGFR4Rx sodium.
|
- HY-132587C
-
|
|
|
siRNAs
siRNA drugs
|
|
Fitusiran sodium scrambled negative control is the sequence scrambled negative control of Fitusiran sodium. Fitusiran (ALN-AT3SC) sodium is a siRNA strategy. Fitusiran delivers siRNA targeting the SERPINC1 gene in hepatocytes to inhibit antithrombin synthesis. Fitusiran sodium enhances thrombin activity and increases Thrombin generation, thereby restoring hemostatic function. Fitusiran sodium can be used in hemophilia-related research .
|
- HY-132583D
-
|
|
|
Antisense Oligonucleotides
|
|
IONIS-DNM2-2.5Rx sodium scrambled negative control is the sequence scrambled negative control of IONIS-DNM2-2.5Rx sodium.
|
- HY-132601C
-
|
|
|
Antisense Oligonucleotides
|
|
Cobomarsen scrambled control is the negative control form of Cobomarsen (HY-132601), with the sequence: ACAUCAUAGUGACU. The modification method is the same as that of Cobomarsen. Cobomarsen sodium is an oligonucleotide inhibitor of miR-155 and can be used in the research of B-cell lymphoma.
|
- HY-158821B
-
|
|
|
Antisense Oligonucleotides
|
|
ISTH0036 sodium scrambled negative control is the sequence scrambled negative control of ISTH0036 sodium (HY-158821A). ISTH0036 sodium is a phosphorothioate LNA-modified antisense oligonucleotide gapmer that selectively targets and downregulates TGF-β2 mRNA. ISTH0036 sodium suppresses TGF-β2 expression, reduces choroidal neovascularization and vascular leakage, inhibits fibrosis, blocks epithelial-to-mesenchymal transition, and inhibits angiogenesis while promoting bleb survival. ISTH0036 sodium exhibits long-lasting, dose-dependent ocular tissue distribution and target engagement in rabbit and non-human primate eyes. ISTH0036 sodium can be used for the study of various ocular disorders, such as glaucoma and neovascular retinal diseases.
|
- HY-132582D
-
|
IONIS-MAPTRx scramble control
|
|
Antisense Oligonucleotides
|
|
Scrambled IONIS-MAPTRx (sodium) is a scrambled sequence of IONIS-MAPTRx sodium (HY-132582C). Scrambled IONIS-MAPTRx (sodium) has the same amino acid composition as the active IONIS-MAPTRx sodium fragment, but the sequence is randomly scrambled. Scrambled IONIS-MAPTRx (sodium) is typically used as a negative control. Scrambled IONIS-MAPTRx (sodium) has potential for studying Alzheimer's disease.
|
- HY-147266C
-
|
|
|
siRNAs
siRNA drugs
|
|
Elebsiran scramble negative control is the scrambled sequence of Elebsiran (HY-147266), and its modification method is the same. Elebsiran scramble negative control can be used as the negative control for Elebsiran.
|
- HY-148100C
-
|
|
|
Aptamers
|
|
Emapticap pegol scramble negative control, an oligonucleotide aptamer, is the negative control of Emapticap pegol (HY-148100) .
|
- HY-145727C
-
|
ISIS 304801 scramble negative control
|
|
Antisense Oligonucleotides
|
|
Volanesorsen scramble negative control is a negative control for volanesorsen (HY-145727) with the sequence: CAUGUTCUTCUGCATGUCAU. Volanesorsen (ISIS 304801) is an antisense oligonucleotide inhibitor of apolipoprotein CIII (apo-CIII) mRNA that can lower triglyceride levels and improve insulin resistance .
|
Your information is safe with us. * Required Fields.
Inquiry Information
- Product Name:
- Cat. No.:
- Quantity:
- MCE Japan Authorized Agent: